Fosun-backed Gland Pharma readies Rp65bn IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Fosun-backed Gland Pharma readies Rp65bn IPO

Jonathan Breen
November 04, 2020 09:45 AM
India_adobe_575x375_20

Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has set the final terms for its Rp64.8bn ($866.5m) IPO in India.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

NomuraEquity IPOsHealth and BiotechEquityChinaCitiIndiaAsiaGreater ChinaHaitong SecuritiesSouth AsiaNortheast AsiaAsia PacificEmerging MarketsSRI
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article